Cell & Gene Therapy manufacturing facility of the future

The future of patient specific medicine, including cell and gene therapy, is driving a need for flexible facility designs to ship product fast.

This is enabled by extensive automation, data transparency, and real time release, with autonomous robotics facilitating high product throughput and environmental monitoring.

The CGT facility will incorporate an automated warehouse, facilitating rapid deployment of personalised treatments to the clinic for patient use.

For more about this, visit:

PM Group engineers architects project managers,cell gene therapy manufacturing,ATMP manufacturing,ATMP future facility,